Anaplastic large cell lymphoma (ALCL), ALK-positive, is a subtype of non-Hodgkin lymphoma characterized by the presence of anaplastic lymphoma kinase (ALK) gene rearrangements. This condition primarily affects lymphatic tissues, particularly in the intrathoracic region. Accurate coding with ICD-10 Code C84.62 is essential for proper diagnosis, documentation, medical billing, and public health reporting, facilitating appropriate treatment and resource allocation.
What is ICD-10 Code C84.62 for Anaplastic large cell lymphoma, ALK-pos, intrathorac nodes?
ICD-10 Code C84.62 specifically denotes Anaplastic large cell lymphoma, ALK-positive, located in the intrathoracic lymph nodes. This code is utilized in clinical documentation and billing to identify this specific subtype of lymphoma, which is crucial for treatment planning and monitoring disease progression. It should be applied when diagnosing patients with confirmed ALK-positive ALCL affecting intrathoracic nodes.
ICD-10 Code C84.62 – Clinical Definition and Explanation of Anaplastic large cell lymphoma, ALK-pos, intrathorac nodes
Anaplastic large cell lymphoma, ALK-positive, is a malignant lymphoproliferative disorder characterized by the proliferation of large, atypical lymphoid cells. The ALK gene rearrangement plays a significant role in the pathogenesis of this lymphoma, leading to aggressive clinical behavior. Prompt diagnosis and treatment are critical due to its potential for rapid progression.
Key Clinical Features:
- Presence of ALK gene rearrangement, typically detected via FISH or PCR.
- Commonly presents with lymphadenopathy, particularly in the chest region.
- May exhibit systemic symptoms such as fever, night sweats, and weight loss.
- Higher incidence in younger adults and children compared to other lymphomas.
ICD-10 Code C84.62 for Anaplastic large cell lymphoma, ALK-pos, intrathorac nodes – SOAP Notes & Clinical Use
ICD-10 Code C84.62 is integral to SOAP notes, facilitating the documentation of patient symptoms, assessments, and treatment plans. This code supports clinical workflows in both acute and chronic care settings, ensuring accurate representation of the patient's condition and guiding appropriate management strategies.
What Does ICD-10 Code C84.62 for Anaplastic large cell lymphoma, ALK-pos, intrathorac nodes Mean in SOAP Notes?
In SOAP notes, ICD-10 Code C84.62 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of ALK-positive anaplastic large cell lymphoma. This coding ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Treatment Options for ICD-10 Code C84.62 – Anaplastic large cell lymphoma, ALK-pos, intrathorac nodes
The management of Anaplastic large cell lymphoma, ALK-positive, often necessitates hospitalization due to the aggressive nature of the disease. Treatment typically involves chemotherapy and may include targeted therapies.
Antibiotic Therapy:
- Not applicable as this is not an infectious condition.
Supportive Care:
- Management of symptoms such as pain and fever.
- Nutritional support to maintain strength during treatment.
- Psychosocial support for patients and families.
Infection Control:
- Standard precautions to prevent infections in immunocompromised patients.
- Monitoring for signs of infection during treatment.
How to Document Symptoms of Anaplastic large cell lymphoma, ALK-pos, intrathorac nodes (ICD-10 C84.62) in SOAP Notes
Subjective:
- Patient reports persistent fatigue and unexplained weight loss.
- Complaints of night sweats and fever over the past month.
- Notable lymphadenopathy in the chest area observed by the patient.
Objective:
- Physical examination reveals enlarged intrathoracic lymph nodes.
- CBC shows anemia and elevated white blood cell count.
- Imaging studies confirm lymphadenopathy in the thoracic region.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Anaplastic large cell lymphoma, ALK-pos, intrathorac nodes (ICD-10 Code C84.62)
Assessment:
- Diagnosis: Anaplastic large cell lymphoma, ALK-positive, affecting intrathoracic nodes.
- Severity: Aggressive lymphoma with systemic symptoms.
- Triggers: Possible viral infections or genetic predisposition.
Plan:
- Initiate chemotherapy regimen including CHOP or similar protocols.
- Consider referral for targeted therapy with ALK inhibitors.
- Schedule follow-up imaging and laboratory tests to monitor response.
Treatment & Plan Section for ICD-10 Code C84.62 – Anaplastic large cell lymphoma, ALK-pos, intrathorac nodes
- First-line treatment typically involves combination chemotherapy.
- Consideration of stem cell transplant in eligible patients.
- Regular monitoring through imaging and laboratory tests to assess treatment efficacy.
- Patient education on potential side effects and symptom management.
Using ICD-10 Code C84.62 for Anaplastic large cell lymphoma, ALK-pos, intrathorac nodes in Billing & SOAP Note Compliance
- Ensure accurate documentation of symptoms and clinical findings in SOAP notes.
- Use C84.62 in conjunction with relevant CPT codes for billing purposes.
- Align treatment plans with clinical guidelines to support justified billing.
- Document any comorbidities or complications to enhance coding accuracy.
Related ICD-10 Codes Often Used with Anaplastic large cell lymphoma, ALK-pos, intrathorac nodes
- C84.61 – Anaplastic large cell lymphoma, ALK-neg, intrathorac nodes
- C83.90 – Hodgkin lymphoma, unspecified, unspecified site
ICD-10 Code C84.62 in Medical Billing and Insurance for Anaplastic large cell lymphoma, ALK-pos, intrathorac nodes
ICD-10 Code C84.62 is crucial for billing in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.
Billing Notes:
- Document all relevant clinical findings and treatment plans to support the ICD-10 claim.
- Use C84.62 in appropriate settings, including inpatient and outpatient care.
- Ensure that all chart elements align with coding guidelines for compliance.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 85025 | Complete blood count (CBC) with automated differential white blood cell count. |
| 71260 | Computed tomography, thorax, with contrast material. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C84.62 for Anaplastic large cell lymphoma, ALK-pos, intrathorac nodes
What are the common symptoms of Anaplastic large cell lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and pain in affected areas.
How is Anaplastic large cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy to confirm the presence of ALK-positive cells. Laboratory tests may also be conducted.
What treatment options are available for Anaplastic large cell lymphoma?
Treatment often includes chemotherapy, targeted therapy for ALK-positive cases, and may involve stem cell transplantation depending on the patient's condition and response to initial therapy.
How does ICD-10 Code C84.62 impact billing?
ICD-10 Code C84.62 is essential for accurate billing, ensuring that healthcare providers are reimbursed for services related to the diagnosis and treatment of Anaplastic large cell lymphoma.
